Genitourinary

Prostate:

CIRB #H-45137/ NRG #GU009 (PREDICT-RT): Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Prostate RNA Expression/Decipher to Individualize Concurrent Therapy with RadiaTion PREDICT-RT) (pending IRB)